Abstract

Mendelian randomization (MR) is an approach that uses genetic variants associated with a modifiable exposure or biological intermediate to estimate the causal relationship between these variables and a medically relevant outcome. Although it was initially developed to examine the relationship between modifiable exposures/biomarkers and disease, its use has expanded to encompass applications in molecular epidemiology, systems biology, pharmacogenomics, and many other areas. The purpose of this review is to introduce MR, the principles behind the approach, and its limitations. We consider some of the new applications of the methodology, including informing drug development, and comment on some promising extensions, including two-step, two-sample, and bidirectional MR. We show how these new methods can be combined to efficiently examine causality in complex biological networks and provide a new framework to data mine high-dimensional studies as we transition into the age of hypothesis-free causality.

Keywords

Mendelian randomizationCausality (physics)PharmacogenomicsCausal inferenceComputer scienceData scienceEconometricsBiologyComputational biologyBioinformaticsGeneticsMathematicsGenetic variants

Affiliated Institutions

Related Publications

Publication Info

Year
2015
Type
review
Volume
16
Issue
1
Pages
327-350
Citations
554
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

554
OpenAlex

Cite This

David M. Evans, George Davey Smith (2015). Mendelian Randomization: New Applications in the Coming Age of Hypothesis-Free Causality. Annual Review of Genomics and Human Genetics , 16 (1) , 327-350. https://doi.org/10.1146/annurev-genom-090314-050016

Identifiers

DOI
10.1146/annurev-genom-090314-050016